People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the latest evidence on screening for chlamydia and gonorrhea and ultimately issued an update to their 2014 recommendation.
The new recommendation, published in JAMA, deems screening for chlamydia and gonorrhea "critical because these STIs often do not cause symptoms, which makes them harder to detect," according to USPSTF vice-chair Michael Barry, MD.
Are you seeing a rise in STI cases in your practice?
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More